(Q41265657)

28 September 2017

Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells (English)

1 reference

Juan Carlos Izpisúa Belmonte

28 September 2017

0 references

0 references

13

object named as

Juan Carlos Izpisua Belmonte

1 reference

28 September 2017

1

Hsin-Kai Liao

1 reference

28 September 2017

9

Tomoaki Hishida

1 reference

28 September 2017

Ying Gu

2

1 reference

28 September 2017

Arturo Diaz

3

1 reference

28 September 2017

John Marlett

4

1 reference

28 September 2017

Yuta Takahashi

5

1 reference

28 September 2017

Mo Li

6

1 reference

28 September 2017

Keiichiro Suzuki

7

1 reference

28 September 2017

Ruo Xu

8

1 reference

28 September 2017

Chan-Jung Chang

10

1 reference

28 September 2017

Concepcion Rodriguez Esteban

11

1 reference

28 September 2017

John Young

12

1 reference

28 September 2017

language of work or name

English

0 references

publication date

10 March 2015

1 reference

28 September 2017

Nature Communications

1 reference

28 September 2017

6

1 reference

28 September 2017

6413

1 reference

https://scigraph.springernature.com/pub.10.1038/ncomms7413

28 September 2017

0 references

cites work

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

HIV-1 gene therapy at pre-integration and provirus DNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

HIV-1 proviral DNA excision using an evolved recombinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

The challenge of finding a cure for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Evolution and classification of the CRISPR-Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

RNA-guided genetic silencing systems in bacteria and archaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Multiplex genome engineering using CRISPR/Cas systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

When is it time for reverse transcription to start and go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Modulation of HIV-1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

CRISPR/Cas, the immune system of bacteria and archaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

HIV-1 latency in monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

High-efficiency targeted editing of large viral genomes by RNA-guided nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Functional human endogenous retroviral LTR transcription start sites are located between the R and U5 regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Group II introns designed to insert into therapeutically relevant DNA target sites in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Genetic and functional characterization of the LTR of HIV-1 subtypes A and C circulating in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

The regulation of HIV-1 gene expression: the emerging role of chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Structure-based analysis of the molecular recognitions between HIV-1 TAR-RNA and transcription factor nuclear factor-kappaB (NFkB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

Genome-scale CRISPR-Cas9 knockout screening in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

DNA targeting specificity of RNA-guided Cas9 nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

siRNA-directed inhibition of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

inferred from DOI database lookup

7 January 2021

based on heuristic

Fungal genetics: the fruitful consequences of a little self-love

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS7413

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NCOMMS7413

1 reference

28 September 2017

0 references

1 reference